Naukri.com's Hiring Outlook Survey for 2020 reveals the jobs and sectors that saw a surge in demand during the pandemic.
While 2017 was a record year for private equity investments in India after $23.5 billion in 660 deals, 2018 too has begun with a bang.
The intention of the government is to cap prices of drugs that are essential and which the public widely uses.
At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.
A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments.
Govt bans brands with annual sales worth Rs 3,728 crore.
As Sunny Leone's film, Mastizaade, hit screens amidst a wave of unprecedented social media support for her, Ritika Bhatia finds out what India thinks of the actor.
The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
One of the reasons for the failure, say industry experts and financial analysts, is that Emami strayed too far from its core with sanitary napkins.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances